Science Explorer Back to mapMap
Discussion
Researcher · Simcere Pharmaceutical (China) · China

Renhong Tang

Renhong Tang publishes mostly in Molecular Biology, Oncology and Immunology, on topics such as Monoclonal and Polyclonal Antibodies Research, Immune Cell Function and Interaction and CAR-T cell therapy research.

OpenAlex
World rank
#1,344,700
of 7,710,434 ranked researchers
Rank in China
#197,728
of 978,568
Works
75
Citations
1k
Citations per work
13.5
h-index
14
i10-index 19Top 55% in Molecular Biology
Renhong Tang

What does Renhong Tang research?

Renhong Tang's work is mostly in Medicine (30%), Biochemistry, Genetics and Molecular Biology (22%), Immunology and Microbiology (13%).

Life Sciences: 27 works · 35.8% of their workBiochemistry, Genetics and Molecular Biology: 17 works · 22.4% of their workMolecular Biology: 17 works · 22.4% of their workImmunology and Microbiology: 10 works · 13.4% of their workImmunology: 10 works · 13.4% of their workEverything else: 25 works · 33.8% of their workHealth Sciences: 23 works · 30.4% of their workMedicine: 23 works · 30.4% of their workOncology: 12 works · 15.4% of their workRadiology, Nuclear Medicine and Imaging: 4 works · 6.0% of their workInfectious Diseases: 4 works · 5.0% of their workPulmonary and Respiratory Medicine: 3 works · 4.0% of their workTHEIR WORKRenhong Tang75works
Life Sciences36%Health Sciences30%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Biochemistry, Genetics and Molecular Biology1722.4%
    2. Immunology and Microbiology1013.4%
  2. Everything else2533.8%
    1. Medicine2330.4%
  1. 1Molecular Biology22% of their works
  2. 2Oncology15% of their works
  3. 3Immunology13% of their works
  4. 4Radiology, Nuclear Medicine and Imaging6% of their works
  5. 5Infectious Diseases5% of their works
  6. 6Pulmonary and Respiratory Medicine4% of their works

Research topics

Which keywords describe Renhong Tang's research?

The keywords of their largest research topics: Cancer Immunotherapy, Glycosylation, Immunity, Cancer, Fc Receptors, Therapeutic Antibodies, CAR T Cells and Chimeric Antigen Receptor.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 20 words, with their numbers
  1. Cancer Immunotherapy152 topics
  2. Glycosylation152 topics
  3. Immunity122 topics
  4. Cancer102 topics
  5. Fc Receptors101 topic
  6. Therapeutic Antibodies101 topic
  7. CAR T Cells91 topic
  8. Chimeric Antigen Receptor91 topic
  9. NK Cell Recognition91 topic
  10. Natural Killer Cells91 topic
  11. Antigen Presentation61 topic
  12. Coronavirus61 topic
  13. Dendritic Cells61 topic
  14. SARS-CoV-261 topic
  15. DNA Damage51 topic
  16. Glycans51 topic
  17. Immune System51 topic
  18. Repair51 topic
  19. VEGF51 topic
  20. endothelial progenitor cells51 topic

Where does Renhong Tang work?

Renhong Tang's main affiliation in the publication record is Simcere Pharmaceutical (China), China.

How many publications and citations does Renhong Tang have?

OpenAlex counts 75 works and 1,011 citations for Renhong Tang, an h-index of 14, ranking #1,344,700 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Other researchers named Renhong Tang

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Renhong Tang. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.